Publications by authors named "Gavin Preston"

Claim this Profile
M
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
Talha Munir, Sean Girvan, David A Cairns, Adrian Bloor, David Allsup, Gavin Preston

N Engl J Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse.
Matthew R Wilson, Amy A Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Gavin Preston

Am J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
Talha Munir, David A Cairns, Adrian Bloor, David Allsup, Kate Cwynarski, Gavin Preston

N Engl J Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax ramp-up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.
Rocio Figueroa-Mora, Alexandros Rampotas, Daniel Halperin, Tina Worth, Jennifer Vidler, Gavin Preston

Br J Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Peter Hillmen, Alexandra Pitchford, Adrian Bloor, Angus Broom, Moya Young, Gavin Preston

Lancet Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.
Matthew R Wilson, Toby A Eyre, Amy A Kirkwood, Nicole Wong Doo, Carole Soussain, Gavin Preston

Blood· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nodules, nodes and non-functioning macrophages: A risk with ibrutinib therapy.
Peter Melville, Farheena Mohammed, Chris RuiWen Kuo, Jack Bradley, Gavin Preston

J R Coll Physicians Edinb· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective observational study to evaluate the clinical outcomes and routine management of patients with chronic lymphocytic leukaemia treated with idelalisib and rituximab in the UK and Ireland (RETRO-idel).
Toby A Eyre, Gavin Preston, Huseini Kagdi, Amin Islam, Toby Nicholson

Br J Haematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery.
Matthew R Wilson, Toby A Eyre, Nicolas Martinez-Calle, Matthew Ahearne, Katrina E Parsons, Gavin Preston

Blood Adv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of daratumumab combination regimen in patients with multiple myeloma: A combined analysis of phase III randomized controlled trials.
Thura W Htut, Kyaw Z Thein, Alastair Lawrie, Jane Tighe, Gavin Preston

EJHaem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes.
Gavin C Preston, Linda V Sinclair, Aneesa Kaskar, Jens L Hukelmann, Maria N Navarro

EMBO J· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leucoerythroblastic anaemia, abnormal bone scan and prostate cancer with a primary haematological diagnosis.
Gavin Preston, David Meiklejohn, Naveena Thomas

Br J Haematol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of KLF2 modulation on the transcriptional program and function of CD8 T cells.
Gavin C Preston, Carmen Feijoo-Carnero, Nick Schurch, Victoria H Cowling, Doreen A Cantrell

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism.
Andrew N Macintyre, David Finlay, Gavin Preston, Linda V Sinclair, Caryll M Waugh

Immunity· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S-adenosyl homocysteine hydrolase is required for Myc-induced mRNA cap methylation, protein synthesis, and cell proliferation.
Maria Elena Fernandez-Sanchez, Thomas Gonatopoulos-Pournatzis, Gavin Preston, Margaret A Lawlor, Victoria H Cowling

Mol Cell Biol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis